In all seriousness, Cowen issued a MNTA report today essentially echoing the points in #msg-61955835—i.e. that Teva’s Lovenox ANDA is not credible and that Teva may settle the Copaxone litigation.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.